JB Exchange/Justified Laboratories sold unapproved skin tag and mole removal serums online, FDA says.
What happened
In August 2022, FDA reviewed www.justifiedlaboratories.com and found it took orders for Skincell Advanced and Skincell. FDA said website claims showed the products were intended to remove skin tags and moles, making them unapproved new drugs. FDA found this through a website review, not an inspection.
What FDA found
The products are unapproved new drugs because the website claims they treat or remove moles and skin tags.
FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)The products are new drugs not generally recognized as safe and effective for their claimed uses.
FD&C Act section 201(p), 21 U.S.C. 321(p)No FDA-approved applications are in effect for the products, so selling them violates the law.
FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d) and 355(a)The website claims establish that the products are intended for use as drugs.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)FDA warns that no OTC drugs can legally be sold for mole or skin tag removal and that self-treatment can delay cancer diagnosis and cause injury or scarring.
What FDA wants
FDA asks the company to notify it in writing within 15 working days of the specific steps taken to address the violations, including steps to prevent recurrence and related documentation. If corrective actions cannot be completed, the company must state the reason for delay and the time within which it will complete them.
Who should pay attention
- online sellers of skin tag or mole removal products
- brands making drug-like claims for cosmetics or serums
- e-commerce platforms hosting such product pages
This is a summary. Read the original letter on fda.gov.